(Q46190550)

20 December 2017

title

Fragile histidine triad gene inactivation in lung cancer: the European Early Lung Cancer project (English)

1 reference

20 December 2017

1 reference

2

1 reference

20 December 2017

Alessandra Fabbri

7

1 reference

20 December 2017

Paolo Bossi

15

1 reference

20 December 2017

Carla Verri

Carla Verri

1

0 references

Francesca Andriani

Francesca Andriani

8

0 references

Luca Tavecchio

Luca Tavecchio

10

0 references

Gabriella Sozzi

Gabriella Sozzi

18

0 references

John K. Field

John K Field

16

0 references

Elisabeth Brambilla

17

Elisabeth Brambilla

1 reference

20 December 2017

author name string

Davide Conte

3

1 reference

20 December 2017

Triantafillos Liloglou

4

1 reference

20 December 2017

Anna Livio

5

1 reference

20 December 2017

Aurelien Vesin

6

1 reference

20 December 2017

Christian Brambilla

9

1 reference

20 December 2017

Giuseppe Calarco

11

1 reference

20 December 2017

Elisa Calabrò

12

1 reference

20 December 2017

Andrea Mancini

13

1 reference

20 December 2017

Diego Tosi

14

1 reference

20 December 2017

EUELC Consortium

19

1 reference

20 December 2017

language of work or name

English

0 references

publication date

18 December 2008

1 reference

20 December 2017

American Journal of Respiratory and Critical Care Medicine

published in

1 reference

20 December 2017

volume

179

1 reference

20 December 2017

issue

5

1 reference

20 December 2017

page(s)

396-401

1 reference

20 December 2017

The FHIT gene 3p14.2 is abnormal in lung cancer.

cites work

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200807-1153OC

Restoration of fragile histidine triad (FHIT) expression induces apoptosis and suppresses tumorigenicity in lung and cervical cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200807-1153OC

Allele-specific chromosome 3p deletions occur at an early stage in the pathogenesis of lung carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200807-1153OC

Fragile histidine triad (FHIT) gene abnormalities in lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200807-1153OC

Aberrant methylation of the FHIT gene in chronic smokers with early stage squamous cell carcinoma of the lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200807-1153OC

Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200807-1153OC

The fragile genes FHIT and WWOX are inactivated coordinately in invasive breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200807-1153OC

Fragile genes as biomarkers: epigenetic control of WWOX and FHIT in lung, breast and bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200807-1153OC

Loss of fragile histidine triad gene expression in advanced lung cancer is consequent to allelic loss at 3p14 locus and promoter methylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200807-1153OC

Cohypermethylation of p16 and FHIT promoters as a prognostic factor of recurrence in surgically resected stage I non-small cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200807-1153OC

Clonality and prognostic implications of p53 and epidermal growth factor receptor somatic aberrations in multiple primary lung cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200807-1153OC

Double-strand break damage and associated DNA repair genes predispose smokers to gene methylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200807-1153OC

Smoking molecular damage in bronchial epithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200807-1153OC

Use of a cytokine gene expression signature in lung adenocarcinoma and the surrounding tissue as a prognostic classifier.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200807-1153OC

Prediction of venous metastases, recurrence, and prognosis in hepatocellular carcinoma based on a unique immune response signature of the liver microenvironment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200807-1153OC

10.1164/RCCM.200807-1153OC

21 January 2018

Identifiers

DOI

1 reference

20 December 2017

PubMed ID

19096006

1 reference

20 December 2017